FDA approves the first CAR T treatment for relapsed or refractory mantle cell lymphoma
87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus
87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus
New platform provides faster identification of defects that impact device performance
Leading clinical scientists and health professionals have come together to discuss the latest diagnostic and point-of-care solutions at this critical time
The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting
Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe
Find out how LC-MS technology is being used to quantify the experimental drug remdesivir
The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test
The NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered
Thermo Fisher Scientific’s ImmunoCAP Specific IgE alpha-Gal Allergen Component test helps clinicians pinpoint a potentially fatal allergy often resulting from tick bites
This on-demand webinar shows how cutting-edge liquid handling, automation, and detection technologies can increase speed and efficiency in your lab
AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage
Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)
Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus
The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes
Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets
Avacta to begin clinical validation of the high-throughput COVID-19 laboratory test in collaboration with the UK government CONDOR program
A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases
Promega automated sample preparation solution added to CDC COVID-19 test protocol
The test is intended to expand availability of COVID-19 screening resources in central Ohio
Siemens Healthineers, Waters, Abbott, and Beckman Coulter among those recognized during celebration of top technologies advancing clinical science
Interim data shows strong antibody and T-cell responses in all evaluated participants
Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms
xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing